FibroGen, Inc. (FGEN)
8.875
+0.37
(+4.35%)
USD |
NASDAQ |
Dec 10, 15:28
FibroGen Market Cap: 35.87M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assertio Holdings, Inc. | 75.57M |
| Perspective Therapeutics, Inc. | 191.42M |
| Skye Bioscience, Inc. | 38.15M |
| Theravance Biopharma, Inc. | 884.74M |
| Myomo, Inc. | 41.32M |
Market Cap Related Metrics
| PE Ratio | 0.2256 |
| PS Ratio | 30.23 |
| Price | 8.875 |
| Earnings Yield | 443.2% |
| Normalized PE Ratio | 0.2180 |